Atlas Trials

Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer

Clinical trial NCT00080860 · COMPLETED

Trial details

NCT number
NCT00080860
Sponsor
National Institutes of Health Clinical Center (CC)
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer
Start date
2004-02-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.